Back to search
Hyperphosphatemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperphosphatemia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperphosphatemia trials you may qualify forA phase 3, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…
The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions…
A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.
During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate le…
A Phase 2a, Multicenter, Randomized, Open-label, Active Drug-controlled Trial to Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patie…
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on hemodialysis
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysis
This study will be conducted to assess the safety and tolerability of ferric citrate in pediatric participants with hyperphosphatemia related to chronic kidney…